Influence of format on in vitro penetration of antibody fragments through porcine cornea
Authors:
Open Access
- 1 September 2005
- journal article
- other
- Published by BMJ in British Journal of Ophthalmology
- Vol. 89 (9) , 1205-1209
Abstract
Aim: Antibody fragments, appropriately formulated, can penetrate through the ocular surface and thus have potential as therapeutic agents. The aim was to investigate the influence of protein fragment format on the kinetics and extent of ocular penetration in vitro. Methods: Immunoglobulin single chain variable domain fragments of a murine monoclonal antibody with specificity for rat CD4 were engineered with a 20 or 11 amino acid linker by assembly polymerase chain reaction, expressed in Escherichia coli and purified by chromatography. Fab fragments of the parental antibody were prepared by papain digestion. Antibody fragments were formulated with a penetration and a viscosity enhancer and were applied to the surface of perfused pig corneas for up to 10 hours in vitro. Penetration was quantified by flow cytometry on rat thymocytes. Results: 20-mer antibody fragments formed natural monomers and dimers following purification that could be separately isolated, while 11-mer fragments were dimeric. All formats of fragment (20-mer monomers and dimers, 11-mer dimers, Fab) showed penetration through the pig cornea after 6 hours of intermittent topical administration. Conclusion: Antibody fragments of different shapes and sizes can penetrate the cornea after topical administration, thereby increasing the potential of this class of proteins for topical ophthalmic use.Keywords
This publication has 27 references indexed in Scilit:
- Penetration of engineered antibody fragments into the eyeClinical and Experimental Immunology, 2002
- A simple corneal perfusion chamber for drug penetration and toxicity studiesBritish Journal of Ophthalmology, 2001
- Human Conjunctiva Contains High Endothelial Venules That Express Lymphocyte Homing ReceptorsExperimental Eye Research, 1999
- Penetration into the Anterior Chamber Via the Conjunctival/Scleral PathwayJournal of Ocular Pharmacology and Therapeutics, 1997
- Corneal and Conjunctival/Scleral Penetration of p-Aminoclonidine, AGN 190342, and Clonidine in Rabbit EyesCurrent Eye Research, 1990
- Mechanisms of corneal drug penetration II: Ultrastructural analysis of potential pathways for drug movementJournal of Pharmaceutical Sciences, 1988
- Die Lymphdrainage von Cornea, Limbus und Conjunctiva*Klinische Monatsblätter für Augenheilkunde, 1987
- Authentic T helper CD4 (W3/25) antigen on rat peritoneal macrophages.Journal of Experimental Medicine, 1985
- Corneal Penetration and Ocular Bioavailability of DrugsJournal of Ocular Pharmacology and Therapeutics, 1985
- PERMEABILITY OF HORSERADISH PEROXIDASE IN THE RABBIT CORNEAL EPITHELIUMActa Ophthalmologica, 1974